Gleevec and Nephrolithiasis - from FDA reports


Summary

Nephrolithiasis is found among people who take Gleevec, especially for people who are male, 40-49 old , have been taking the drug for 1 - 6 months, also take medication Zometa, and have Osteoporosis. This review analyzes which people have Nephrolithiasis with Gleevec. It is created by eHealthMe based on reports of 26,043 people who have side effects when taking Gleevec from FDA , and is updated regularly.

What to expect?

If you take Gleevec and have Nephrolithiasis, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Gleevec and have Nephrolithiasis

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Nov, 21, 2017

26,043 people reported to have side effects when taking Gleevec.
Among them, 119 people (0.46%) have Nephrolithiasis


Number of reports submitted per year:

Could Gleevec cause Nephrolithiasis?

Time on Gleevec when people have Nephrolithiasis *:

  • < 1 month: 22.22 %
  • 1 - 6 months: 44.44 %
  • 6 - 12 months: 11.11 %
  • 1 - 2 years: 11.11 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 11.11 %
  • 10+ years: 0.0 %

Gender of people who have Nephrolithiasis when taking Gleevec *:

  • female: 34.78 %
  • male: 65.22 %

Age of people who have Nephrolithiasis when taking Gleevec *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 5.77 %
  • 20-29: 3.85 %
  • 30-39: 9.62 %
  • 40-49: 30.77 %
  • 50-59: 21.15 %
  • 60+: 28.85 %

Top conditions involved for these people *:

  • Osteoporosis (11 people, 9.24%)
  • Gastrointestinal Stromal Tumor (10 people, 8.40%)
  • Preventive Health Care (7 people, 5.88%)
  • Malignant Soft Tissue Neoplasm (5 people, 4.20%)
  • High Blood Pressure (3 people, 2.52%)

Top co-used drugs for these people *:

  • Zometa (18 people, 15.13%)
  • Rocephin (12 people, 10.08%)
  • Compazine (12 people, 10.08%)
  • Aredia (12 people, 10.08%)
  • Allegra (11 people, 9.24%)

Top other side effects for these people *:

  • Nausea (30 people, 25.21%)
  • Fatigue (27 people, 22.69%)
  • Pain (26 people, 21.85%)
  • Back Pain (23 people, 19.33%)
  • Abdominal Pain (23 people, 19.33%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Nephrolithiasis when taking Gleevec?

Expand the study to include all drugs with the same ingredients

Nephrolithiasis and drugs with ingredients of imatinib mesylate.

Expand the study to include reports from both FDA and eHealthMe

Nephrolithiasis and Gleevec from FDA and eHealthMe reports

Gleevec

Gleevec has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml). (latest outcomes from Gleevec 26,410 users)

Nephrolithiasis

Nephrolithiasis (calculi in the kidneys) has been reported by people with multiple sclerosis, rheumatoid arthritis, osteoporosis, high blood pressure, crohn's disease (latest reports from 25,384 Nephrolithiasis patients).

Browse all side effects of Gleevec

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Nephrolithiasis

Nephrolithiasis

Could your condition cause Nephrolithiasis

Nephrolithiasis

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Gleevec and have Nephrolithiasis.

Questions to the study

More questions >

User reviews to the study

More reviews >